MEDICAMENT COMBINE POUR LE TRAITEMENT D'UNE MALADIE AUTO–IMMUNE

N° de brevet: EP1815867 (A1)
Date de publication: 2007-08-08
Inventeur(s): TAGASHIRA SHUZO [JP];FUKUSHIMA A [JP];
Demandeur(s): DAINIPPON SUMITOMO PHARMA CO [JP];
Classification: A61K45/06;A61K31/18;A61K31/42;A61K31/426;A61K31/519;A61K31/5377;A61K31/635;A61P1/04;A61P1/16;A61P3/00;A61P3/08;A61P3/10;A61P5/14;A61P7/00;A61P7/04;A61P7/06;A61P11/00;A61P13/02;A61P15/08;A61P15/12;A61P17/00;
N° de demande: EP20050805515 20051102 
Numéro(s) de priorité: WO2005JP20221 20051102;JP20040318771 20041102 
It is intended to provide a combination drug for preventing and/or treating an autoimmune disease. More specifically speaking, a combination drug for preventing and/or treating an autoimmune disease which contains a CaMKII inhibitor and a disease-modifying antirheumatic drug; a medicinal composition, a commercial package, a kit, etc. for the combination; an enhancer for the effect of preventing and/or treating an autoimmune disease of a disease-modifying antirheumatic drug which contains a CaMKII inhibitor as the active ingredient; a method of screening a CaMKII inhibitor appropriately usable in combination, and so on.

Copyright © 2008 Patfr.com Tous droits réservés. Contact